semaglutide and how it works Tirzepatide vs. Semaglutide: What You Should Know Mechanism of Action | Ozempic®

They are expressed throughout the central nervous system and the cardiovascular system, meaning their impact is truly systemic

The implication for practice is that incretin therapy is not a substitute for ApoB-lowering therapy in established ASCVD but is complementary: aggressive ApoB lowering addresses the lipid driver of atherogenesis, while incretin therapy addresses residual inflammatory, vascular, and metabolic risk

J.et al (2017)

This rapidly growing field is continuously uncovering new therapeutic peptides designed to target specific diseases and conditions, offering hope for more personalized and effective treatments

Metabolites 15 (4), 276 (2025)

Mirjalili MH, et al